These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34195951)

  • 1. Wearable cardioverter-defibrillators after myocardial infarction: a review of its clinical utility and unmet needs in current clinical practice.
    Hioki H; Kozuma K; Kobayashi Y; Ando K; Morino Y; Kishihara J; Ako J; Ikari Y
    Cardiovasc Interv Ther; 2022 Jan; 37(1):53-59. PubMed ID: 34195951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report.
    Andresen H; Sasko B; Patschan D; Pagonas N; Ritter O
    J Med Case Rep; 2021 May; 15(1):243. PubMed ID: 33993888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    Olgin JE; Pletcher MJ; Vittinghoff E; Wranicz J; Malik R; Morin DP; Zweibel S; Buxton AE; Elayi CS; Chung EH; Rashba E; Borggrefe M; Hue TF; Maguire C; Lin F; Simon JA; Hulley S; Lee BK;
    N Engl J Med; 2018 Sep; 379(13):1205-1215. PubMed ID: 30280654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden cardiac death while waiting: do we need the wearable cardioverter-defibrillator?
    Israel C; Staudacher I; Leclercq C; Botto GL; Scherr D; Fach A; Duru F; Zylla MM; Katus HA; Thomas D
    Clin Res Cardiol; 2022 Nov; 111(11):1189-1197. PubMed ID: 35305126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Wearable Cardioverter Defibrillator as a Bridge to Implantable Cardioverter Defibrillator.
    Weinstock J
    Card Electrophysiol Clin; 2018 Mar; 10(1):11-16. PubMed ID: 29428131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective.
    Botto GL; Mantovani LG; Cortesi PA; De Ponti R; D'Onofrio A; Biffi M; Capucci A; Casu G; Notarstefano P; Scaglione M; Zanotto G; Boriani G;
    Int J Cardiol; 2022 Jun; 356():12-18. PubMed ID: 35395289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE; Abraham WT; Bianco NR; Kern KB; Mirro M; Rao SV; Rhee EK; Solomon SD; Szymkiewicz SJ
    J Am Coll Cardiol; 2013 Nov; 62(21):2000-2007. PubMed ID: 23916930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death.
    Elbayomi M; Weyand M; Seitz T; Harig F
    Ann Noninvasive Electrocardiol; 2023 Mar; 28(2):e13048. PubMed ID: 36723848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The wearable cardioverter defibrillator - temporary protection against sudden cardiac death].
    Almqvist M; Mattsson G; Magnusson P
    Lakartidningen; 2019 Apr; 116():. PubMed ID: 31192401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.
    Sinha AM; Bense J; Hohenforst-Schmidt W
    J Interv Card Electrophysiol; 2021 Nov; 62(2):401-407. PubMed ID: 33200285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    Skowasch D; Ringquist S; Nickenig G; Andrié R
    PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the wearable cardioverter-defibrillator the answer for early post-myocardial infarction patients at risk for sudden death?: mind the gap.
    Zei PC
    J Am Coll Cardiol; 2013 Nov; 62(21):2008-2009. PubMed ID: 23916931
    [No Abstract]   [Full Text] [Related]  

  • 15. [Wearable cardioverter-defibrillators: clinical experience and future perspectives].
    Romanò M; Zorzoli F; Bertona R; Graziano G; Villani R
    G Ital Cardiol (Rome); 2018; 19(7):448-459. PubMed ID: 29989602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the wearable cardioverter defibrillator in clinical practice.
    Chung MK
    Cardiol Clin; 2014 May; 32(2):253-70. PubMed ID: 24793801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The wearable cardioverter defibrillator as a bridge to implantable defibrillator post myocardial infarction: what do we know?
    Barsheshet A; Vamvouris T; Goldenberg I
    Expert Rev Med Devices; 2016 Jul; 13(7):627-32. PubMed ID: 27333818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of early death after myocardial infarction in patients with reduced left ventricular ejection fraction. The search for new indications for cardioverter-defibrillator implantation (ICD).
    Pres D; Tajstra M; Mitkowski P; Ciślak A; Bujak K; Kaźmierczak J; Sterliński M; Mizia-Stec K; Sierpiński R; Gąsior M; Szumowski Ł; Kalarus Z
    Kardiol Pol; 2021; 79(12):1343-1352. PubMed ID: 34897630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.
    Winther-Jensen M; Kjaergaard J; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Kragholm K; Christensen EF; Hassager C
    Eur Heart J Acute Cardiovasc Care; 2017 Mar; 6(2):144-154. PubMed ID: 28058848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator.
    Zishiri ET; Williams S; Cronin EM; Blackstone EH; Ellis SG; Roselli EE; Smedira NG; Gillinov AM; Glad JA; Tchou PJ; Szymkiewicz SJ; Chung MK
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):117-28. PubMed ID: 23275233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.